Pablo Proano, MD
Psychiatry · Seattle, WANPI 1639109036
Payments from drug & device makers
Across 1,153 payments — averaging $97.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$46K
- Otsuka America Pharmaceutical, Inc.$35K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$7K
- AbbVie$4K
- Neurocrine Biosciences, Inc.$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- plus $14K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 102 | $46,230 |
| Otsuka America Pharmaceutical, Inc. | 130 | $34,849 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 153 | $7,463 |
| AbbVie(2 entities) | 202 | $4,434 |
| Neurocrine Biosciences, Inc. | 86 | $2,675 |
| Takeda Pharmaceuticals U.S.A., Inc. | 88 | $2,248 |
| Sunovion Pharmaceuticals Inc. | 8 | $1,729 |
| Alkermes, Inc. | 47 | $1,691 |
| Axsome Therapeutics, Inc. | 30 | $1,544 |
| Johnson & Johnson | 37 | $1,458 |
| Supernus Pharmaceuticals, Inc. | 56 | $1,072 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 10 | $945 |
| Lundbeck LLC | 35 | $726 |
| Corium, LLC | 22 | $666 |
| Vanda Pharmaceuticals Inc. | 15 | $654 |
| E.r. Squibb & Sons, L.L.C. | 12 | $621 |
| Jazz Pharmaceuticals Inc. | 8 | $471 |
| Avanir Pharmaceuticals, Inc. | 22 | $464 |
| Idorsia Pharmaceuticals US Inc | 16 | $338 |
| Alfasigma USA, Inc. | 19 | $330 |
| Tris Pharma Inc | 10 | $295 |
| Ironshore Pharmaceuticals Inc. | 5 | $242 |
| Eisai Inc. | 12 | $204 |
| Shire North American Group Inc | 9 | $171 |
| Bausch Health US, LLC | 5 | $101 |
| Adlon Therapeutics L.p. | 5 | $93 |
| Noven Therapeutics, LLC | 4 | $83 |
| Merck | 4 | $69 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
How this compares
$111,883 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Seattle
- Chester RobachinskiSeattle$1.1M
- James BowenSeattle$79K
- Veronika ZantopSeattle$57K
- Jesse McClellandSeattle$39K
- Lina FineSeattle$30K
- Jonathan BuchholzSeattle$7K
- Steven MitchellSeattle$7K
- Randall EspinozaSeattle$6K
- John KernSeattle$6K
- Gerard ZanolliSeattle$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.